NM_000307.5:c.506C>T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_000307.5(POU3F4):​c.506C>T​(p.Pro169Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000148 in 1,206,558 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 44 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. P169P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00013 ( 0 hom., 4 hem., cov: 24)
Exomes 𝑓: 0.00015 ( 0 hom. 40 hem. )

Consequence

POU3F4
NM_000307.5 missense

Scores

3
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 5.77

Publications

1 publications found
Variant links:
Genes affected
POU3F4 (HGNC:9217): (POU class 3 homeobox 4) This gene encodes a member of the POU-III class of neural transcription factors. This family member plays a role in inner ear development. The protein is thought to be involved in the mediation of epigenetic signals which induce striatal neuron-precursor differentiation. Mutations in this gene are associated with X chromosome-linked nonsyndromic mixed deafness. [provided by RefSeq, Dec 2012]
POU3F4 Gene-Disease associations (from GenCC):
  • nonsyndromic genetic hearing loss
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • X-linked mixed hearing loss with perilymphatic gusher
    Inheritance: XL Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • mitochondrial non-syndromic sensorineural hearing loss
    Inheritance: Mitochondrial Classification: SUPPORTIVE Submitted by: Orphanet
  • choroideremia-deafness-obesity syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0077652335).
BP6
Variant X-83508830-C-T is Benign according to our data. Variant chrX-83508830-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 43348.
BS2
High Hemizygotes in GnomAd4 at 4 XL,Mitochondrial gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
POU3F4NM_000307.5 linkc.506C>T p.Pro169Leu missense_variant Exon 1 of 1 ENST00000644024.2 NP_000298.3 P49335A0A2R8Y739

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
POU3F4ENST00000644024.2 linkc.506C>T p.Pro169Leu missense_variant Exon 1 of 1 NM_000307.5 ENSP00000495996.1 A0A2R8Y739
ENSG00000279437ENST00000625081.1 linkn.385G>A non_coding_transcript_exon_variant Exon 1 of 1 6
ENSG00000307072ENST00000823276.1 linkn.654G>A non_coding_transcript_exon_variant Exon 2 of 2
ENSG00000307072ENST00000823277.1 linkn.601G>A non_coding_transcript_exon_variant Exon 2 of 2

Frequencies

GnomAD3 genomes
AF:
0.000133
AC:
15
AN:
112563
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00526
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000657
GnomAD2 exomes
AF:
0.000322
AC:
54
AN:
167897
AF XY:
0.000272
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00652
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000411
Gnomad OTH exome
AF:
0.000945
GnomAD4 exome
AF:
0.000149
AC:
163
AN:
1093995
Hom.:
0
Cov.:
31
AF XY:
0.000111
AC XY:
40
AN XY:
359899
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26330
American (AMR)
AF:
0.00
AC:
0
AN:
34700
Ashkenazi Jewish (ASJ)
AF:
0.00612
AC:
118
AN:
19292
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30053
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53419
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40215
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4129
European-Non Finnish (NFE)
AF:
0.0000274
AC:
23
AN:
839893
Other (OTH)
AF:
0.000479
AC:
22
AN:
45964
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
10
20
30
40
50
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000133
AC:
15
AN:
112563
Hom.:
0
Cov.:
24
AF XY:
0.000115
AC XY:
4
AN XY:
34711
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30962
American (AMR)
AF:
0.00
AC:
0
AN:
10770
Ashkenazi Jewish (ASJ)
AF:
0.00526
AC:
14
AN:
2660
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3547
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2727
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6206
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53249
Other (OTH)
AF:
0.000657
AC:
1
AN:
1521
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00117
Hom.:
8
Bravo
AF:
0.000170
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000346
AC:
1
ExAC
AF:
0.000231
AC:
28

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Sep 12, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The Pro169Leu variant in POU3F4 has been identified by our laboratory in one mal e individual with hearing loss (LMM-unpublished data), but was absent from large population studies. Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. In summary, the clinical significance of the Pro169Leu variant is uncertain. -

Inborn genetic diseases Uncertain:1
Apr 28, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.506C>T (p.P169L) alteration is located in exon 1 (coding exon 1) of the POU3F4 gene. This alteration results from a C to T substitution at nucleotide position 506, causing the proline (P) at amino acid position 169 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

not provided Benign:1
Feb 14, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.10
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
18
DANN
Uncertain
0.98
FATHMM_MKL
Benign
0.61
D
LIST_S2
Benign
0.72
.;T
M_CAP
Benign
0.056
D
MetaRNN
Benign
0.0078
T;T
MetaSVM
Benign
-0.45
T
PhyloP100
5.8
PrimateAI
Uncertain
0.52
T
PROVEAN
Benign
-1.8
N;.
REVEL
Benign
0.22
Sift
Benign
0.053
T;.
Sift4G
Uncertain
0.034
D;.
Vest4
0.18
MVP
0.84
MPC
1.1
ClinPred
0.057
T
GERP RS
5.3
gMVP
0.63
Mutation Taster
=75/25
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200696740; hg19: chrX-82763838; API